glp-1 in type 2 diabetes receptor agonists are increasingly used to treat and obesity, and trials have shown reductions cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 receptor agonism: a transformative
Description
Botfield HF, Uldall MS, Westgate CSJ, et al
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults with Overweight or Obesity: The STEP 8 Randomized Clinical Trial
Can You Boost GLP-1 Naturally?.
However, not every medication in this space works exactly the same way
Therefore, improving the gut microbiota positively affects urinary tract infections
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation
